Glenmark Pharmaceuticals Inc., USA, is a prominent player in the global pharmaceutical industry, headquartered in the United States. Founded in 2001, the company has established a strong presence in key operational regions, including North America and Europe, focusing on the development and manufacturing of innovative medicines. Specialising in a diverse range of therapeutic areas such as dermatology, respiratory, and oncology, Glenmark is recognised for its commitment to research and development, which has led to the introduction of unique generic and specialty pharmaceuticals. The company has achieved significant milestones, including numerous product approvals and a robust pipeline of new therapies, solidifying its market position as a trusted provider of high-quality healthcare solutions.
We don't have data for Glenmark Pharmaceuticals Inc., USA, but we can show you information about their parent organization instead.
View parent company